Vergence is a bioceutical branding, marketing and sales company focused on creating health products to penetrate the fast-growing market for safe and effective natural products that meet unmet wellness needs. Its key products are geared towards natural cannabinoid enhanced goods.
Comfort, our new proprietary nutraceutical was developed by Abattis to activate the endocannabinoid system and nourish endorphin release in response to chronic pain. Comfort is enhanced with non-cannabis or hemp cannabinoids, instead sourcing its phytocannabinoids from sources like Alpinia Galangal and Capsicum Annuum. Comfort is manufactured in accordance with Canadian Natural Health Products (NHP) monographs and under the US Food and Drug Administration’s (FDA) Current Good Manufacturing Practice (CGMP) regulations.
Comfort Extra Strength, with hemp-based cannabinoids, is expected to launch in early 2019.